UNICA IRIS Institutional Research Information System

DEL ZOMPO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 276.731
NA - Nord America 16.033
AS - Asia 6.372
SA - Sud America 1.057
AF - Africa 171
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 12
Totale 300.396
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 271.706
US - Stati Uniti d'America 15.819
CN - Cina 2.328
SG - Singapore 2.313
NL - Olanda 1.101
UA - Ucraina 1.024
BR - Brasile 822
SE - Svezia 777
VN - Vietnam 596
DE - Germania 587
FI - Finlandia 467
GB - Regno Unito 427
FR - Francia 313
HK - Hong Kong 248
IN - India 192
BD - Bangladesh 129
KR - Corea 110
CA - Canada 109
AR - Argentina 68
MX - Messico 68
RU - Federazione Russa 59
IQ - Iraq 55
ZA - Sudafrica 49
TR - Turchia 47
JP - Giappone 44
EC - Ecuador 41
ES - Italia 41
PL - Polonia 41
AT - Austria 40
ID - Indonesia 37
CO - Colombia 36
BE - Belgio 35
PK - Pakistan 31
PH - Filippine 30
MA - Marocco 27
VE - Venezuela 26
UZ - Uzbekistan 24
EG - Egitto 22
SA - Arabia Saudita 22
JO - Giordania 21
CL - Cile 20
MY - Malesia 20
AU - Australia 19
IE - Irlanda 17
TN - Tunisia 17
AZ - Azerbaigian 16
PY - Paraguay 16
CZ - Repubblica Ceca 14
IL - Israele 14
KE - Kenya 13
KZ - Kazakistan 12
PS - Palestinian Territory 12
BO - Bolivia 10
DZ - Algeria 10
EU - Europa 10
IR - Iran 9
NP - Nepal 9
BG - Bulgaria 8
MU - Mauritius 8
UY - Uruguay 8
LT - Lituania 7
PE - Perù 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
DK - Danimarca 6
GR - Grecia 6
JM - Giamaica 6
MD - Moldavia 6
OM - Oman 6
PA - Panama 6
QA - Qatar 6
RO - Romania 6
TH - Thailandia 6
TW - Taiwan 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
NG - Nigeria 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
KG - Kirghizistan 4
LB - Libano 4
SN - Senegal 4
AO - Angola 3
HU - Ungheria 3
NO - Norvegia 3
PR - Porto Rico 3
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MK - Macedonia 2
NI - Nicaragua 2
Totale 300.364
Salva come PNG Salva come JPEG
Città #
Cagliari 266.337
Uta 4.583
Fairfield 1.669
Ashburn 1.390
Woodbridge 1.165
Singapore 1.157
Amsterdam 1.077
Chandler 1.012
Houston 888
San Jose 839
Dallas 699
Boardman 668
Seattle 660
Wilmington 655
Ann Arbor 640
Cambridge 532
Jacksonville 519
Nyköping 472
Beijing 407
Helsinki 287
Los Angeles 259
Dearborn 256
New York 235
Hong Kong 218
Santa Clara 202
Hefei 200
Ho Chi Minh City 183
Lauterbourg 182
Nanjing 179
The Dalles 179
Boston 166
Shanghai 138
Council Bluffs 136
Munich 112
Buffalo 110
Hanoi 108
Seoul 106
San Diego 92
Shenyang 72
Milan 69
Redwood City 69
Dong Ket 64
Hangzhou 64
Atlanta 63
Nanchang 62
São Paulo 61
Frankfurt am Main 53
Guangzhou 52
Jiaxing 52
Changsha 51
Mountain View 51
Norwalk 50
Rome 50
London 48
Orem 47
Verona 46
Chicago 45
Hebei 44
Tianjin 43
Montreal 39
Toronto 39
Pune 38
Redondo Beach 37
Johannesburg 36
Brussels 35
Jinan 35
Warsaw 34
Rio de Janeiro 33
Brooklyn 31
Tokyo 31
Nuremberg 30
Zhengzhou 30
Da Nang 29
Orange 28
Denver 27
Stockholm 27
Haiphong 25
Washington 25
Phoenix 23
Vienna 23
Columbus 22
Shenzhen 22
Auburn Hills 21
Southend 21
Tashkent 21
Chennai 20
Falls Church 20
Poplar 20
Amman 19
Belo Horizonte 19
Ningbo 18
San Mateo 18
Kunming 17
Sassari 17
Mumbai 16
Saint Petersburg 16
Baku 15
San Francisco 15
Baghdad 14
Detroit 14
Totale 290.893
Salva come PNG Salva come JPEG
Nome #
Carbamazepine augmentation in lithium refractory bipolar patients: a prospective study on long-term prophylactic effectiveness 12.132
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.372
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.266
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.766
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.718
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.627
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.572
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 3.512
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.512
Continuation versus discontinuation of lithium during pregnancy: a retrospective case series 3.204
An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function 3.178
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.146
Analysis of the influence of microRNAs in lithium response in bipolar disorder 3.066
Dopaminergic and serotonergic genes in bipolar disorder: A case control study in a Sardinian population 3.060
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 3.051
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.050
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 3.011
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.924
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.923
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.896
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.889
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.885
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.825
Involvement of core clock genes in lithium response 2.818
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.746
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.715
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.679
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.676
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.670
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.670
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.649
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.598
Online information seeking by patients with bipolar disorder: results from an international multisite survey 2.587
null 2.498
Prediction of Lithium Response using Clinical Data 2.490
High leptin levels are associated with migraine with aura 2.470
Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? 2.463
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 2.456
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 2.412
Pharmacogenomics of bipolar disorder 2.404
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.380
Association study in three different populations between the GPR88 gene and major psychoses 2.359
Internet use by patients with bipolar disorder: Results from an international multisite survey 2.334
Fifteen-year follow-up of thyroid function in lithium patients 2.313
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.302
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.192
Cellular models to study bipolar disorder: a systematic review 2.179
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 2.151
Solar insolation in springtime influences age of onset of bipolar I disorder 2.142
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 2.106
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 2.088
Association between solar insolation and a history of suicide attempts in bipolar I disorder 2.077
Convergent genetic and expression data implicate immunity in Alzheimer's disease 2.030
Characterisation of age and polarity at onset in bipolar disorder 2.027
Long term lithium treatment and survival from external causes including suicide 1.997
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.982
null 1.980
Internet use by older adults with bipolar disorder: international survey results 1.962
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.940
Clinical factors associated with lithium treatment response in bipolar disorder patients from India 1.896
A genetic risk score is differentially associated with migraine with and without aura 1.853
null 1.842
No evidence of association between dopamine D3 receptor gene and bipolar affective disorder 1.794
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.791
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.745
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.728
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.670
A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness 1.659
Prediction of lithium response using genomic data 1.655
Admixture analysis of age at onset in bipolar disorder 1.648
Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia 1.604
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.601
Farmaci per il trattamento delle cefalee primitive e per il controllo del vomito 1.595
Clozapine toxicity due to a multiple drug interaction: a case report 1.566
null 1.525
Influence of light exposure during early life on the age of onset of bipolar disorder 1.492
null 1.449
null 1.424
Genetic linkage and association studies in affective disorders 1.417
null 1.414
Relationship between sunlight and the age of onset of bipolar disorder: an international multisite study 1.404
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.388
Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes 1.382
null 1.334
Age at Onset in Sardinian Bipolar I Patients: Evidence for Three Subgroups 1.308
Influence of birth cohort on age of onset cluster analysis in bipolar I disorder 1.285
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.272
Six-year follow-up of thyroid function during lithium treatment 1.268
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.268
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 1.242
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.236
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.232
A48G polymorphism in the D1 receptor genes associated with bipolar I disorder 1.220
Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients 1.218
Evaluation of lithium response in episodic cluster headache: a retrospective case series 1.208
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.203
Thyroid abnormalities during lithium treatment 1.200
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 1.200
null 1.161
null 1.146
Totale 228.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 383.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 383.603
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.120 0 0 0 0 0 0 0 0 0 0 0 2.120
2021/202214.194 1.828 1.069 802 973 1.113 903 1.028 822 1.259 1.390 1.580 1.427
2022/202320.690 1.579 2.881 2.643 1.777 1.670 2.293 887 1.674 1.569 1.324 1.592 801
2023/202420.950 1.043 1.047 885 1.700 1.899 3.489 2.967 1.300 908 1.333 2.379 2.000
2024/202576.726 26.215 24.066 9.999 4.266 2.622 2.549 3.955 259 520 1.409 400 466
2025/202612.603 765 472 1.451 1.141 1.004 921 2.352 766 880 1.582 972 297
Totale 300.974